Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice

Effective pharmacologic treatments for psychiatric disorders are available, but their effect is limited due to patients’ genetic heterogeneity and low compliance-related to frequent adverse events. Only one third of patients respond to treatment and experience remission. Pharmacogenetics is a relati...

Descripción completa

Detalles Bibliográficos
Autores principales: van Westrhenen, R., van Schaik, R. H. N., van Gelder, T., Birkenhager, T. K., Bakker, P. R., Houwink, E. J. F., Bet, P. M., Hoogendijk, W. J. G., van Weelden-Hulshof, M. J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117336/
https://www.ncbi.nlm.nih.gov/pubmed/33995044
http://dx.doi.org/10.3389/fphar.2021.640032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117336/
https://www.ncbi.nlm.nih.gov/pubmed/33995044
http://dx.doi.org/10.3389/fphar.2021.640032

Ejemplares similares